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Summary
Background Sexuality is an integral part of overall
health but the impact of neurological diseases on sex-
ual function still receives too little attention.
Aim The aim of this case control study was to com-
pare frequencies and characteristics of sexual dys-
function in women with stable relapsing-remitting
multiple sclerosis (MS) and migraine.
Methods Sexually active women aged 18–50 years
were recruited at the MS and headache outpatient
clinics of a university hospital and asked to complete
questionnaires on sexual function using the multi-
ple sclerosis intimacy and sexuality questionnaire
(MSISQ-19) adapted for patients with migraine, de-
pression using the Beck depression inventory (BDI-II)
and quality of life using the short form-36 question-
naire (SF-36).
Results At least one symptom of sexual dysfunction
was “almost always” or “always” present in 35.7% of
42 patients with MS and in 22.6% of 30 patients with
migraine (p = 0.3). The MSISQ-19 total score did not
differ between the two groups (31.6 ± 10.8 vs. 28.2 ±
11.6, respectively, p = 0.2). Sexual dysfunction was cat-
egorized as primary, secondary and tertiary in 66.7%,
40% and 33.3% of MS patients and in 57.1% (p = 0.7),
71.4% (p = 0.2) and 71.4% (p = 0.1) of migraine pa-
tients, respectively. Depressive symptoms were more
common in women with sexual dysfunction than in
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those without both inMS (p = 0.001) andmigraine (p =
0.006). The SF-36 showed decreasing quality of life
with increasing MSISQ-19 sum scores (mental sub-
scale p < 0.001 and physical subscale p = 0.04).
Conclusions Sexual dysfunction is a major problem
both in women with MS and in women with migraine
and is strongly associated with comorbid depression
and impaired quality of life. Thus, categorizing sex-
uality as done by MSISQ-19 is limited by its complex
biopsychosocial interactions.
Keywords Sexual dysfunction · Multiple sclerosis · Mi-
graine · Depression · Quality of life
Introduction
Sexuality as an integral part of overall health is a com-
plex need and easily affected by health-related, psy-
chosocial and emotional conditions. Multiple sclero-
sis (MS) and migraine are chronic relapsing disorders
particularly affecting young and middle-aged women.
Although awareness of sexual dysfunction related to
MS and migraine has increased in the last few years
[1–4] it still remains underestimated and undertreated
in daily routine practice.
In MS 30–80% of the patients experience sexual
dysfunctions [1], even in early disease stages when se-
vere disability is absent [5] and quality of life mainly
depends on non-motor functions, including a fulfill-
ing sex life [6, 7]. Importance of sexual issues was
rated high by MS patients [8], and there is evidence for
a detrimental impact of sexual dysfunction on mental
aspects of health-related quality of life [6]. Neverthe-
less, problems are usually not reported on patients
own initiative and clinicians interestingly talk about
urinary or bladder problems but avoid talking about
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sexuality [9]. Causes for MS-related sexual dysfunc-
tions are heterogeneous, ranging from causative cere-
bral or spinal demyelination to disturbing neurolog-
ical symptoms and psychosocial consequences, neg-
atively interfering with sexual activity [1, 2]. Accord-
ingly, Sanders [10] conceptualized sexual dysfunctions
defining them as primary, secondary and tertiary con-
sequences of MS.
For migraine even less data on sexual function are
available than for MS. Pathophysiologically, migraine
and sexual desire have been linked to 5-hydroxytryp-
tophan [11]. Clinical studies suggest that the rela-
tionship between migraine, sexual desire and sexual
activity is much more complex than the cliché of “not
tonight honey, I have a headache” [11]. Houle et al.
compared 23 migraine patients to 36 with tension-
type headache (TTH), found significantly higher sex-
ual desire in migraine sufferers than in patients with
TTH and hypothesized that similar serotonergic phe-
nomena may modulate both migraine and sexual de-
sire [11]. In another questionnaire study, one third
of 306 migraine patients reported experiences with
sexual activity during an attack and 60% experienced
pain relief after sexual activity [12].
A few studies only addressed the question of sexual
dysfunction in patients with migraine. Studies in fe-
male headache sufferers not including headache-free
controls showed sexual dysfunction in 90% of the pa-
tients [4, 13]. This dysfunction was related to depres-
sive symptoms but not to the migraine disability as-
sessment scale score (MIDAS) [14], the frequency and
severity of attacks or anxiety [13]. In addition, hy-
poactive sexual desire disorder was found in 20% of
patients with migraine and/or TTH [4]. Controlled
studies confirmed the impact of headache on sexual
life: among 44 patients with migraine, 30 with TTH
and 30 controls, sexual activity was less frequent and
problems in several aspects of sexuality were more
common in both headache groups compared to the
control group [3]. Among female university students,
those with migraine showed a higher health influence
on sexual life, higher levels of sexual pain and lower
sexual satisfaction compared to women without mi-
graine, whereas sexual activity, desire, orgasm and sat-
isfaction from sexual life did not differ between the
two groups [15].
Sufferers from MS and migraine have several fea-
tures in common. Besides the epidemiological char-
acteristics regarding age and gender, the age at onset
and the course of the disease characterized by unpre-
dictable occurrence of bouts or attacks, both disorders
have considerable impact on patient life [16]. Physi-
cal impairment is not limited to MS but is also a hall-
mark of migraine considering that even routine phys-
ical activity may aggravate a migraine attack. More-
over, physical activity may precipitate an attack or it
may be avoided because the patient is afraid of get-
ting or aggravating an attack. Furthermore, both MS
andmigraine are associated with fatigue [17, 18]. Even
though MS is typically considered to be a chronic pro-
gressive disorder, this may also be the case inmigraine
[19, 20]. The most obvious difference betweenMS and
migraine is the degree of physical impairment result-
ing in the long-term course.
Up to now, there has been no study available com-
paring the impact of MS and migraine on sexual func-
tion in women; therefore, the aim of this study was to
evaluate the frequency and characteristics of sexual
dysfunction in female patients with stable relapsing-
remitting MS and with migraine, to elucidate differ-
ences in the impact of these two chronic relapsing
neurological diseases and to assess the relation of sex-
ual dysfunction to depression and quality of life.
Patients and methods
Between 2009 and 2013 women aged 18–50 years
were recruited from the outpatient MS and headache
clinics of a university hospital and gave written in-
formed consent to participate. Inclusion criteria were
a diagnosis of stable relapsing-remitting MS or a di-
agnosis of migraine according to the criteria of the
third edition of the International Classification of
Headache Disorders (ICHD-3 beta) [21]. All MS pa-
tients were free of migraine and all migraine patients
underwent brain magnetic resonance imaging (MRI)
during routine diagnostic work-up to exclude cere-
bral pathologies. Exclusion criteria were other severe
physical illnesses, no sexual intercourse during the
past 6 months, postmenopause, difficulties to fill in
a questionnaire, medication overuse headache, and
lack of fluency in the German language. The study
was approved by the ethics committee of the Medical
University of Vienna.
Evaluation of sexual function, depression and quality
of life (Qol)
Sexual functioning was evaluated by the multiple scle-
rosis intimacy and sexuality questionnaire (MSISQ-
19) [10]. The MSISQ-19 is a self-rating scale, refers
to the previous 6 months and includes 19 symptoms
of sexual dysfunction rated on a scale ranging from
1 (never) to 5 (always). The maximum sum score
is 95 with higher scores indicating more severe sex-
ual dysfunction. An alternative way of analysis is to
use a cut-off method: at least one question of the pri-
mary, secondary or tertiary domain that was answered
with “almost always” or “always” indicates a clinically
significant sexual dysfunction.
Looking for a suitable questionnaire on sexual func-
tion proved to be the most difficult part. We finally de-
cided to use a questionnaire specific to MS as it was
the primary focus of our study and specific question-
naires on sexual function in migraine do not exist.
In our opinion, non-disease specific questionnaires,
such as the female sexual function index [22] or the
Arizona sexual experiences scale [23] pay too little (or








Mean age, years (SD) 34 (7) 32 (9)
Median EDSS 1.75 –
Family status
Single 40.5 % 27.6 %
Married/cohabitation 45.2 % 62.1 %
Divorced 14.3 % 6.9 %
Widowed 0% 3.4 %
Children
Yes 35.7 % 48.3 %
No 64.3 % 51.7 %
Occupation
Apprentice/student 14.3 % 0%
Employed 52.4 % 27.5 %
Self-employed 2.4 % 0%
Housewife 4.8 % 72.4 %
Retired 16.7 % 0%
Unemployed 9.5 % 0%
Education




University 28.6 % 17.2 %
SD standard deviation, EDSS Expanded disability status scale
no) attention to the importance of symptoms asso-
ciated with a chronic disease; however, there are sev-
eral similarities betweenMS andmigraine, which sup-
ported our decision but made it necessary to adapt the
MSISQ-19 for suitability in patients with migraine. In
detail, we asked migraine patients to think about mi-
graine attacks or precipitating symptoms when an-
swering the following questions: feeling of depen-
dency due to migraine, feeling less feminine due to
migraine, exacerbation or significant worsening of mi-
graine symptoms, feeling less confident about sexu-
ality due to migraine and fear of being rejected due
to migraine. The concept of sexual dysfunction de-
fined as primary, secondary or tertiary remained un-
changed for both MS and migraine patients. Primary
sexual dysfunctions referred to impairment of sexual
response or sexual feelings (e.g. altered genital sensa-
tion, decreased libido, problems with arousal and or-
gasm and reduced vaginal lubrication) in MS caused
by demyelination and in migraine by altered seroton-
ergic function. Secondary sexual dysfunctions refer to
changes that indirectly impair sexual response, such
as pain, cognitive or concentration problems. Ter-
tiary sexual dysfunctions are caused by disability-re-
lated psychological, emotional, social and cultural in-
fluences that may interfere with sexual functioning
(e.g. altered self-image, lowered self-esteem, anger,
feeling of rejection, feeling less feminine, isolation,
guilt, change in gender roles and feelings of depen-
dency). Of the 19 items, 5 items refer to primary, 9 to
secondary and 5 items to tertiary sexual dysfunctions.
Quality of life was evaluated by short form 36-ques-
tionnaire (SF-36) [24] and depression by the Beck de-
pression inventory II scale (BDI-II) [25]. The SF-36
is a self-rating questionnaire for evaluating health-re-
lated quality of life (QoL). Subjects have to rate their
QoL during the preceding 4 weeks. Raw scores are
transformed into scores between zero (lowest QoL)
and 100 (best possible QoL). The questions can be
grouped into eight categories (subscales) and in addi-
tion summed scores for a physical andmental compo-
nent can be calculated [24]. The BDI-II is also a self-
rating questionnaire with 21 items and a maximum
summed score of 63 with higher summed scores indi-
cating more severe depression [25].
Statistical analysis
Descriptive statistics (mean ± standard deviation, me-
dian or frequencies and percentages) are given for all
variables. For comparison between groups, paramet-
ric tests were used (t-test). Fisher’s exact test was used
for proportions and Spearman’s rank test for correla-
tion analysis. Analysis was performed using SPSS 20.




We screened 82 female patients of which 6 patients
had no sexual intercourse within the previous 6
months, 3 additional patients were excluded due
to incomplete questionnaires and 1 because of pure
TTH. A final number of 42 MS patients with a me-
dian EDSS of 1.75 and 30 patients with migraine were
included for further analysis. Of the migraine pa-
tients five had an additional diagnosis of TTH. Table 1
provides more demographic characteristics.
Sexual dysfunction
Using the cut-off method 35.7% of MS patients and
22.6% of headache patients had some form of sexual
dysfunction, i. e. at least 1 out of the 19 symptoms
of sexual dysfunction was present “almost always” or
“always” (Fisher’s exact test p = 0.304). Sexual dys-
functions were categorized as primary, secondary or
tertiary in 66.7, 40, and 33.3% of MS patients and in
57.1, 71.4 and 71.4% of headache patients, respec-
tively. Thus, numerically, the prevalence of primary
dysfunction was similar in MS and migraine, whereas
secondary and tertiary dysfunctions were more com-
mon in migraine. None of the differences, however,
were statistically significant (Fisher’s exact test: p =
0.7, p = 0.2, p = 0.1, respectively). Combinations of
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Any form of sexual dysfunction (SD) 35.7 22.6 0.304a
Combined SD 33.4 71.5 0.172a





















Muscle tension or spasticity
Bladder problems
Bowel problems
Shaking of hands or body
Pain or burning sensations in the
body
Problems with body control



























Fear of rejection by partner















For comparison between groups two-sided t-test was used and Fisher’s
exact test was used for proportions
aFisher’s exact test
bTwo-sided t-test
primary, secondary and tertiary sexual dysfunctions
were also numerically more common in patients with
migraine but again the differences were statistically
not significant (33.4% vs. 71.5%, Fisher’s exact test
p = 0.2).
The mean MSISQ-19 summed score was 31.6 ± 10.8
(range 19–69) in MS and 28.2 ± 11.6 (range 19–69)
in migraine (t-test p = 0.2). Table 2 contains further
details on sexual dysfunctions in patients with MS and
migraine.
Severity of the disease
The EDSS score showed a statistically significant
positive correlation to the MSISQ-19 summed score
(Spearman’s rank correlation p = 0.02).
Depression and quality of life
The prevalence and severity of depressive symptoms
assessed by BDI-II was similar in patients with MS
and migraine (Fisher’s exact test p = 0.847). Symptoms
were absent in 47.6% and 48.4%, minimal or mild in
35.7% and 32.2%, moderate in 9.5% and 6.5% and
severe in 7.1% and 9.7%, respectively (Fisher’s exact
test p > 0.05).
Analyzing the entire group of 72 patients, de-
pression was significantly more common in patients
with sexual dysfunction (90.9%) than in those with-
out (34%, Fisher’s exact test p < 0.001) and there
was a positive correlation of BDI-II and MSISQ-19
summed scores (Spearman’s rank correlation p <
0.001). Depression was also significantly associ-
ated with sexual dysfunction when using the cut-off
method and analyzing data separately for MS (Fisher’s
exact test p = 0.001) and migraine (Fisher’s exact test
p = 0.006). Prevalence rates of depression in women
with and without sexual dysfunction were 93.3% and
29.6% in MS (Fisher’s exact test p = 0.001) and 85.7%
and 39.1% in migraine, respectively (Fisher’s exact
test p = 0.006).
With respect to quality of life, the physical summed
score of SF-36 and the pain score were higher in MS
than in migraine (t-test: physical sum score 48 vs. 42,
p = 0.035, pain score: 74 vs. 39, p < 0.001, respec-
tively) indicating that patients with MS experienced
better physical quality of life and less pain than pa-
tients with migraine. In contrast, the mental summed
score, as well as the other subscales of SF-36, did not
show statistically significant differences between MS
andmigraine. In both groups, the physical andmental
summed scores showed a statistically significant neg-
ative correlation with the MSISQ-19 summed score
(Spearman’s rank correlation MS p < 0.001, migraine
p = 0.04).
Discussion
This is the first cross-sectional case control study com-
paring the impact of stable relapsing-remitting MS
and migraine on sexual function in women. Our study
suggests that sexual dysfunction is a major problem
both in women with MS and with migraine. More
than one third of the patients with MS and almost
one quarter of those with migraine had clinically rele-
vant sexual dysfunction, i. e. they experienced at least
1 out of 19 symptoms of the MSISQ-19 almost always
or always during the preceding 6 months. The differ-
ence was statistically not significant. Similarly, the two
patient groups did not differ with respect to primary,
secondary or tertiary sexual dysfunction. In the entire
group of patients and in the two subgroups, sexual
dysfunction was related to depression and impaired
quality of life.
Both MS and migraine show female preponder-
ance and patients share the burden of suffering from
a chronic recurrent neurological disease with un-
predictable clinical exacerbations (i. e. relapse vs.
migraine attack) accompanied by and leading to fur-
ther disease-related problems between attacks, only
one of which being sexual dysfunction. Even though
sexual dysfunctions, such as hypoactive sexual desire
and sexual pain were described in headache patients
[4, 15], our finding that MS and migraine patients
were equally affected at all levels was remarkable.
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Considering the differences in the nature of MS and
migraine, we expected to find significantly more pri-
mary and secondary sexual dysfunctions in MS and
tertiary dysfunctions in both MS and migraine pa-
tients. Of the headache patients four (all with nor-
mal brain MRI) actually reported sexual dysfunctions,
such as reduced lubrication, problems with arousal
and orgasm or reduced libido, all of them classified
as primary according to Sanders’ concept [10], thus
pointing to its limitations. Categorizing sexuality into
levels is limited by its complex biopsychosocial in-
teractions. Even in MS, sexual dysfunctions defined
as primary may not always be the result of underly-
ing pathophysiological central nervous system (CNS)
changes but more a direct consequence of unhappy
partner relationships, other psychological or social in-
fluences or depression [26–28]. Anhedonia, a depres-
sion-specific symptom, is related to lowered sexual
desire, thus probably mimicking primary sexual dys-
function. Indeed, a strong association of depression
and sexual dysfunction was apparent in our study with
only two patients suffering exclusively from sexual
dysfunction without concomitant depression. Similar
results underlining the major negative impact of de-
pression on sexuality have been previously published
[4, 13, 29–31]. A study focusing on sexual dysfunctions
in chronic diseases found that comorbid depression
was frequent and independently determined the pres-
ence of sexual dysfunction [32]. Interestingly, former
studies using MSISQ-19 either did not assess depres-
sion by a specific questionnaire [6, 33, 34] or correla-
tion analysis was only done between depression and
tertiary sexual dysfunction [5]. Furthermore, to the
best of our knowledge there are no MRI studies sup-
porting Sanders’ concept of primary sexual dysfunc-
tions due to causative cerebral demyelination. Con-
sidering all these points, the equal prevalence of the
three domains of the MSISQ-19 in MS and migraine
give rise to doubts about the usefulness of the con-
cept behind the MSISQ-19. Additionally, the preva-
lence of sexual dysfunction in MS is associated with
higher EDSS scores [29, 31]. In this study, patients
were not severely disabled (median EDSS 1.75), even
had a better perception of their physical health and
experienced less bodily pain than headache patients,
as indicated by higher SF-36 physical summed and
pain scores. From a different perspective, the sub-
jectively perceived burden of headache of otherwise
healthy individuals seems to exceed its assumed one,
exerting a negative influence also on sexual life. So far,
a substantial negative impact of headache has been
shown on social and family life, careers and earnings
of headache patients [35]. We cannot comment on the
importance of headache attack frequency or severity
because these data were not systematically collected;
however, the results of Eraslan et al. [13] suggest that
sexual dysfunction in headache patients is not related
to attack frequency or severity.
Interpretation of our study data is limited because
the sample size was small due to serious recruitment
problems, most probably related to the subject of
the study and study methodology requiring face to
face contact with the patients in the setting of an
outpatient clinic. Thus, the study may be biased
towards women with a more open attitude to sex-
ual life. In addition, we cannot exclude that women
with sexual dysfunction were more likely to partic-
ipate in this study. If such bias occurred, it most
likely affected the two study groups similarly. Pro-
viding more information on sexual dysfunctions to
both clinical physicians and patients could help to
remove any taboos and, thus, to overcome recruit-
ment problems in future studies. Another limitation
concerns MSISQ-19, which was not validated for mi-
graine patients, who were however instructed to think
about their migraine when answering the question-
naire. Furthermore, MSISQ-19 made it unfeasible to
examine a healthy control group. Finally, our findings
cannot be transferred to the general population, as
they were recorded in a tertiary centre.
Despite these limitations, the results of our study
suggest that sexual dysfunction is not only a ma-
jor problem in female patients with MS but also in
women with migraine. The frequency of primary,
secondary and tertiary sexual dysfunctions is similar
both in MS and headache patients. Given the fluid
nature of the three dimensions of sexual dysfunction
as defined by Sanders [10], a clear allocation to one
of these levels seems difficult. Comorbid depression
was found in almost all patients, seems to be strongly
associated with sexual dysfunction and may mimic
primary sexual dysfunction. We therefore propose
that diagnosis of sexual dysfunction should only be
made after exclusion or successful treatment of co-
morbid depression.
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